Cargando…
Relevance of TMPRSS2, CD163/CD206, and CD33 in clinical severity stratification of COVID-19
BACKGROUND: Approximately 13.8% and 6.1% of coronavirus disease 2019 (COVID-19) patients require hospitalization and sometimes intensive care unit (ICU) admission, respectively. There is no biomarker to predict which of these patients will develop an aggressive stage that we could improve their qual...
Autores principales: | Martínez-Diz, Silvia, Marín-Benesiu, Fernando, López-Torres, Ginesa, Santiago, Olivia, Díaz-Cuéllar, José F., Martín-Esteban, Sara, Cortés-Valverde, Ana I., Arenas-Rodríguez, Verónica, Cuenca-López, Sergio, Porras-Quesada, Patricia, Ruiz-Ruiz, Carmen, Abadía-Molina, Ana C., Entrala-Bernal, Carmen, Martínez-González, Luis J., Álvarez-Cubero, Maria Jesus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031647/ https://www.ncbi.nlm.nih.gov/pubmed/36969980 http://dx.doi.org/10.3389/fimmu.2022.1094644 |
Ejemplares similares
-
Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
por: Nielsen, Marlene Christina, et al.
Publicado: (2020) -
Tissue Levels of CD80, CD163 and CD206 and Their Ratios in Periodontal and Peri-Implant Health and Disease
por: Yilmaz, Mustafa, et al.
Publicado: (2022) -
Overexpression of CD163, CD204 and CD206 on Alveolar Macrophages in the Lungs of Patients with Severe Chronic Obstructive Pulmonary Disease
por: Kaku, Yoichiro, et al.
Publicado: (2014) -
Characteristics and clinical significance of CD163+/CD206+M2 mono-macrophage in the bladder cancer microenvironment
por: KONG, Xiangjie, et al.
Publicado: (2021) -
Circulating CD14(+)CD163(+)CD206(+) M2 Monocytes Are Increased in Patients with Early Stage of Idiopathic Membranous Nephropathy
por: Hou, Jie, et al.
Publicado: (2018)